Mutations of GJB2 (coding Cx26) might be associated with an increased propensity to develop skin cancer [20]; and germline mutations of this gene are assumed to increase the risk for early onset prostate cancer [21]. This evidence concerns the gene GJB2 and skin neoplasm.